Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
- Title
- Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
- Author
- 김태형
- Keywords
- Idiopathic Pulmonary Fibrosis; Diagnosis; Disease Management; Korea
- Issue Date
- 2019-04
- Publisher
- The Korean Academy of Tuberculosis and Respiratory Diseases
- Citation
- Tuberculosis and Respiratory Diseases, v. 82, NO 2, Page. 102-117
- Abstract
- Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
- URI
- https://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2018.0091https://repository.hanyang.ac.kr/handle/20.500.11754/110782
- ISSN
- 1738-3536; 2005-6184
- DOI
- 10.4046/trd.2018.0091
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
- Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases Part 2. Idiopathic Pulmonary Fibrosis.pdfDownload
- Export
- RIS (EndNote)
- XLS (Excel)
- XML